Last Updated: August 3, 2026

Litigation Details for Orlando Gateway Partners, LLC (Bankr. M.D. Fla. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Orlando Gateway Partners, LLC (Bankr. M.D. Fla. 2015)

Docket 6:15-bk-03448 Date Filed 2015-04-20
Court United States Bankruptcy Court, M.D. Florida Date Terminated
Cause Assigned To
Jury Demand Referred To
Parties UNITED STATES TRUSTEE - ORL
Patents 9,186,413
Attorneys Esther A McKean
Firms Akerman Senterfitt, Post
Link to Docket External link to docket
Small Molecule Drugs cited in Orlando Gateway Partners, LLC
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Details for Orlando Gateway Partners, LLC (Bankr. M.D. Fla. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-04-20 External link to document
2015-04-20 22 lndividual oebior(s) Y°s 2 $°'°° TOTAL 20 $9,186,413.00 $54,204,216.89 Case 6:15…any E Community Secured Claim or Exemption 22. Patents, copyrights and other X intellectual property Give External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation Summary and Analysis for Orlando Gateway Partners, LLC (Case No. 6:15-bk-03448)

Last updated: July 16, 2026

Executive summary

The docket reference “6:15-bk-03448” identifies a bankruptcy matter in the U.S. bankruptcy courts, with proceedings impacting Orlando Gateway Partners, LLC’s estate and creditors’ rights. A litigation “summary and analysis” requires the underlying docket events, parties, claims, adversary proceedings, court orders, and any appeal or settlement record. No case-specific docket content is available in the prompt, so a complete and accurate litigation summary cannot be produced.

What court controls case 6:15-bk-03448 for Orlando Gateway Partners, LLC?

Answer: Not determinable from the provided input. Bankruptcy docket “6:15-bk-03448” is insufficient to identify the bankruptcy unit, trustee/administrator, or jurisdiction without the court docket text.

How to map “6:15-bk-03448” to the correct bankruptcy district?

Answer: Not determinable from the provided input.

What litigation activity exists in 6:15-bk-03448 (adversary proceedings, motions, orders)?

Answer: Not determinable from the provided input. A litigation summary must be anchored to docket entries (case filings and hearings) and outcomes.

What types of disputes typically appear?

Answer: Not determinable for this specific case without docket entries.

Who are the key parties and what claims are asserted in Orlando Gateway Partners, LLC’s bankruptcy?

Answer: Not determinable from the provided input. A litigation analysis requires identifying creditors, secured claim holders, debtors, and any litigation opponents named in the docket.

What is the debtor’s litigation posture?

Answer: Not determinable from the provided input.

Are there settlements or confirmed plans that affect litigation risk?

Answer: Not determinable from the provided input. Plan confirmation, disclosure statement outcomes, and settlement agreements are typically required to analyze litigation exposure.

Did the case involve plan confirmation, dismissal, or conversion?

Answer: Not determinable from the provided input.

What is the status of adversary proceedings in 6:15-bk-03448?

Answer: Not determinable from the provided input. Adversary proceeding case numbers and dispositions are required.

Which issues drive adversary proceedings?

Answer: Not determinable for this specific case without docket content.

How do any court rulings change creditor recoveries in 6:15-bk-03448?

Answer: Not determinable from the provided input. Recovery impacts require claim allowances, valuation rulings, and distribution milestones.

What orders are most material to payouts?

Answer: Not determinable from the provided input.

What appeal activity exists from orders in Orlando Gateway Partners, LLC?

Answer: Not determinable from the provided input. Appeals require appellate docket references and decision dates.

Did any appeals stay or reverse bankruptcy court rulings?

Answer: Not determinable from the provided input.

Key takeaways

  • “6:15-bk-03448” is not enough to generate a case-specific litigation summary or analysis.
  • A reliable litigation summary must cite docket events, parties, motion practice, orders, and outcomes, none of which are provided in the prompt.

FAQs

  1. What does “6:15-bk-03448” mean?
    A bankruptcy docket identifier format, but the prompt does not provide the court name or docket text needed for case-specific conclusions.

  2. Was there an adversary proceeding associated with Orlando Gateway Partners, LLC?
    Not determinable without adversary docket entries.

  3. Who filed major motions (stay relief, claim objection, conversion) in 6:15-bk-03448?
    Not determinable without docket information.

  4. Did Orlando Gateway Partners, LLC’s bankruptcy end in plan confirmation, dismissal, or conversion?
    Not determinable without the case’s procedural history.

  5. Are there settlements that resolve specific disputes in this matter?
    Not determinable without settlement entries and confirmation/order text.

References

(No sources cited because the prompt provides no docket content or external references to cite.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.